A Generic Platform for Cellular Screening Against Ubiquitin Ligases.

Area of Science:

• Biochemistry
• Molecular Biology
• Drug Discovery

Background:

• Ubiquitin signalling is crucial for cellular processes; its deregulation is linked to various diseases.
• E3 ubiquitin ligases offer substrate selectivity and are promising therapeutic targets.
• Ubiquitin drug discovery faces challenges due to pathway complexity and lack of high-throughput screening methods.

Purpose of the Study:

• To develop a novel cellular technology for identifying selective inhibitors against RING type E3 ubiquitin ligases.
• To establish a robust high-throughput screening platform for targeting E3 ligases.

Main Methods:

• Development of a Ubiquitin Ligase Profiling system.
• Utilizing a single co-transfection of cells with assay vectors.
• Measuring E3 ubiquitin ligase catalytic activity within the cellular environment.

Main Results:

• A novel and generic cellular technology for E3 ubiquitin ligase inhibitor screening was created.
• The system enables readout of E3 ligase activity in a cellular context.
• The platform facilitates high-throughput screening for inhibitors of RING type E3 ligases.

Conclusions:

• The Ubiquitin Ligase Profiling system provides a robust platform for inhibitor development.
• This technology offers new opportunities for targeting difficult E3 ligase enzymes.
• The system advances ubiquitin drug discovery for disease-related targets.